logo
Plus   Neg
Share
Email

Thermo Fisher Gets Expansion Of EUA For TaqPath COVID-19 Combo Kit - Quick Facts

Thermo Fisher Scientific Inc. (TMO) said Monday it has received an expansion of its Emergency Use Authorization or EUA for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a digital health testing company.

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit. This will enable individuals to self-collect nasal swab specimens after it is determined by a healthcare provider to be appropriate, based on results of a COVID-19 questionnaire.

Samples collected using the Everlywell self-collection kit may be processed by CLIA-certified laboratories running Thermo Fisher's TaqMan SARS-CoV-2 RNase P Assay Kit. The results can be obtained through the Everlywell online platform.

"As part of our commitment to keep our workplaces safe and healthy, Thermo Fisher launched its own pilot program to provide at-home collection kits and online access to test results for more than 10,000 colleagues across the country. Now, leveraging Everlywell's capabilities, we can expand our own use and offer other organizations the confidence to move forward with return-to-workplace strategies that reduce the risk of spreading the virus," said Mark Stevenson, executive vice president and chief operating officer at Thermo Fisher Scientific.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT